Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
08/2002
08/20/2002US6436957 Indole derivatives as 5-HT1 agonists
08/15/2002WO2002062771A1 Novel 2-benzoxazolyl benzene derivatives and their use as uv screening agents
08/15/2002WO2002028821A3 Propionic acid derivatives with ppar-alpha activating properties
08/15/2002US20020111378 Inhibitors of IMPDH enzyme
08/15/2002US20020111372 Fused heteroaromatic glucokinase activators
08/15/2002US20020111368 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
08/15/2002US20020111273 Insecticides, fungicides, miticides, plant safening agents
08/15/2002CA2434535A1 Novel 2-benzoxazolyl benzene derivatives and their use as uv screening agents
08/14/2002EP1230227A1 Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors
08/14/2002EP1077718B1 Enhancement of oxazolidinone antibacterial agents activity by arginine derivatives
08/14/2002EP0807111B1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/14/2002EP0790974B1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors
08/13/2002US6433188 Fused heteroaromatic glucokinase activators
08/13/2002US6433180 Carboxylic acids for synthesis of taxane derivatives
08/13/2002US6433116 Oxazoline or oxazine acetoacetate aqueous coating compositions
08/13/2002US6432999 Pyrazole substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
08/13/2002US6432962 Antiinflammatory agents
08/13/2002US6432958 2-piperazinoalkylaminobenzoazole derivatives: dopamine receptor subtype specific ligands
08/13/2002US6432921 Oligopeptides
08/13/2002CA2111447C Hypoglycemic thiazolidinediones and intermediates
08/08/2002WO2002060879A2 Bacterial gyrase inhibitors and uses thereof
08/08/2002WO2001093840A3 Ligands of integrin receptors
08/08/2002US20020107406 Calcium receptor-active compounds
08/08/2002US20020107403 Sulfonyl oxazolones and their use for combating undesirable microorganisms
08/08/2002US20020107402 Aminoaryl oxazolidinone N-oxides
08/08/2002US20020107396 3-cycloalkyl- or propyl-2-(3,4-dihalophenyl)-N-quinolinyl-, quinazolinyl-, or quinoxolinyl-propionamide.
08/08/2002US20020107345 Complex of a selected transition metal with a monoanionic ligand that has at least three atoms that may coordinate to the transition metal, one of which is an oxygen at and one of which is a nitrogen in an imine radical
08/08/2002US20020107271 Heterocyclic aromatic oxazole compounds and use thereof
08/08/2002US20020107270 Selective inhibitory action on cyclooxygenase- 2 and are expected to be useful as anti-inflammatory agents with less side-effects such as digestive tract disorders.
08/08/2002US20020107269 Inhibiting cell proliferation and treating cancer
08/08/2002US20020107252 Novel Compounds
08/08/2002US20020106762 Generating preerential compound for use as prophylactic agent; obtain chemical intermediate, incubate with enzyme, recover prophylactic agent
08/07/2002EP1229037A1 Heterocyclic N-acetonylbenzamides and their use as fungicides
08/07/2002EP1229028A1 Heterocyclic N-acetonylbenzamides and their use as fungicides
08/07/2002EP1229027A1 Heterocyclic N-acetonylbenzamides and their use as fungicides
08/07/2002EP1228760A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
08/07/2002EP1228061A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
08/07/2002EP1228053A1 Substituted piperazine derivatives, the production and use thereof as inhibitors of the microsomal triglyceride transfer protein (mtp)
08/07/2002EP1227847A2 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy
08/07/2002EP1107949A4 Process for preparing certain phenyl urea compounds
08/07/2002EP0770599B1 Process for the preparation of aromatic or heteroaromatic sulfonyl halides
08/07/2002CN1362951A Dihetero-substituted metalloprotease inhibitors
08/01/2002WO2002059098A1 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
08/01/2002WO2002059086A1 Carboxamides as fungicides in agriculture
08/01/2002WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
08/01/2002WO2002028841A3 Reagents for labeling biomolecules having aldehyde or ketone moieties
08/01/2002WO2001078654A3 Halogentated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
08/01/2002US20020103398 Double bond acts as a rigidifying element, for unexpected potency and selectivity for inhibition of inducible nitric oxide synthase over the constitutive isoforms
08/01/2002US20020103387 Compounds which mimic the chemical and biological properties of discodermolide
08/01/2002US20020103241 Such as N-benzooxazol-2-yl-3-cyclopentyl-2-(4-methanesulfonyl -phenyl)-propionamide for increasing insulin secretion in the treatment of type II diabetes
08/01/2002US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
08/01/2002US20020103199 Fused heteroaromatic glucokinase activators
08/01/2002US20020103192 Perfluoroalkylketones, ketooxazoles, ketoamides, ketoesters, and diketones, and their dihydroxy derivatives, such as 7-((1,1'-biphenyl)-3-yloxy)-1-(1,3-oxazol-2-yl)-1-heptanone
08/01/2002US20020103186 Use against multiply resistant gram positive pathogens; have a diazine moiety attached to the phenyloxazolidinone which is further substituted by heterocyclic, aryl, substituted aryl, heteroaroamatic ring
08/01/2002CA2433819A1 Carboxamides as fungicides in agriculture
07/2002
07/31/2002EP1227095A2 A process for the purification of (S)-4-((3-(dimethylamino)ethyl)-1H-indol-5yl)-methyl)-2-oxazolidinone
07/31/2002EP1227081A1 Process for the preparation of oxyiminoalkanoic acid derivatives
07/31/2002EP1226116A1 Processes for the preparation of sumatriptan and related compounds
07/31/2002EP0883611B1 Azolyl piperazinyl phenyl oxazolidinone antimicrobials
07/31/2002CN1361772A Substituted heteroaryloxyacetanilides and their use as herbicides
07/31/2002CN1088456C Substituted oxazolidine calpain and/or cathepsin B inhibitors
07/30/2002US6426354 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
07/25/2002WO2002057251A2 Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues
07/25/2002WO2002057236A1 Phenyl derivatives
07/25/2002WO2002056827A2 Substituted felbamate derived compounds
07/25/2002WO2002032874A3 Substituted heterocyclic compounds for treating multidrug resistance
07/25/2002US20020099217 Process for preparing azacycloalkanoylaminothiazoles
07/25/2002US20020099215 For therapy and prophylaxis of P-glycoprotein-mediated multidrug resistance
07/25/2002US20020099074 Novel anilide compounds and drugs containing the same
07/25/2002US20020099050 E.g., 1-(1,4-benzodioxan-5-ylcarbonyl)-1,2,3,6-tetrahydro-pyridine), 1-(1,3-benzodioxol-5-ylcarbonyl)-piperidine); and 1-(1,3-benzodioxol-5-ylcarbonyl)-1,2,3,6-tetrahydropyridine
07/25/2002DE10102322A1 New disubstituted and trisubstituted benzene derivatives useful as coagulation inhibitors for the treatment of thromboembolic diseases
07/25/2002CA2435371A1 Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues
07/25/2002CA2427058A1 Substituted felbamate derived compounds
07/24/2002EP1224178A1 Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics
07/24/2002EP1224177A1 Process for preparing oxazolines from tetrahydrofurans
07/24/2002EP1224171A1 Beta disubstituted metalloprotease inhibitors
07/24/2002EP1223933A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
07/24/2002EP1223921A2 Tissue factor antagonists and methods of use thereof
07/24/2002EP0699192B1 Substituted oxazolyl compounds for the treatment of inflammation
07/24/2002EP0684945B1 Pyrazole- or isoxazole-substituted alkyl amide acat inhibitors
07/24/2002CN1360584A Preparation of aromatic bisoxazoline
07/24/2002CN1360580A Substd. benzoyl ketones, methods for producing them and their use as herbicides
07/24/2002CN1360573A Phthalamide derivs., intermediates in production thereof, and agricultural/horticultural insecticides and method of using same
07/24/2002CN1088061C Dihalopropene compounds, insecticidal/acaricidal agent contg. same, and intermediates
07/23/2002US6423849 Process of preparing 5-(2-substituted-4-nitrophenyl)-oxazole, novel oxazole compound, and process of preparing the same
07/23/2002US6423729 Therapeutic or prophylactic agent for glomerulopathy
07/23/2002US6423709 Methods of using novel compounds as neuro-protective agents
07/23/2002US6423699 Contraceptives
07/18/2002WO2002056013A2 Oxazolidinone photoaffinity probes, uses and compounds
07/18/2002WO2002022557A3 2-amino-2-alkyl-4 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
07/18/2002WO2002004409A3 Tetrahydrobenzothiazole analogues as neuroprotective agents
07/18/2002US20020095054 Process to produce oxazolidinones
07/18/2002US20020094938 Unsaturated phenolic compound forms an amide bond with amine of fragrance; 2-(2,4-dimethylcyclohex-3-en-1-yl),3-(2-(2,4 -dihydroxyphenyl)ethenylcarbonyl)oxazolidine for example; laundry detergents, shampoos and hair conditioners
07/18/2002US20020094453 Metal coordination compound, luminescence device and display apparatus
07/18/2002CA2432162A1 Oxazolidinone photoaffinity probes, uses and compounds
07/17/2002EP1083900B1 Use of of oxazolidinones for the preparation of a medicament for transdermal delivery
07/17/2002EP0915857B1 Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetics and pharmaceuticals
07/17/2002CN1359384A Taxane derivatives and processes for the preparation thereof
07/17/2002CN1087735C Process for preparation of pesticidal 1-(haloaryl) heteroyclic compounds
07/16/2002US6420561 Piperazinyl or piperidinyl acid derivatives for treatment of rheumatic diseases, arthritis due to gout and antiinflammatory agents